|
OMIM |
Link |
Information gain |
01 |
|
LPL
|
[NCBI]
|
0.0123114
|
|
|
ATHS
|
[NCBI]
|
0.00930291
|
|
|
APOB
|
[NCBI]
|
0.00325116
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.00300706
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 6
|
[NCBI]
|
0.00192188
|
|
|
cholesterol level quantitative trait locus 2
|
[NCBI]
|
0.00192188
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 5
|
[NCBI]
|
0.00192188
|
|
|
coronary heart disease, susceptibility to, 4
|
[NCBI]
|
0.00192188
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.00140088
|
|
|
FCHL
|
[NCBI]
|
0.00117128
|
|
|
APOE
|
[NCBI]
|
0.00109423
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.00107966
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.00107966
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.00107966
|
|
|
ABL
|
[NCBI]
|
0.00106396
|
|
|
LCAT
|
[NCBI]
|
0.00105663
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
0.000912844
|
|
|
carnitine deficiency, myopathic
|
[NCBI]
|
0.000715325
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
0.000672471
|
|
|
hyperalphalipoproteinemia
|
[NCBI]
|
0.00066281
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000645084
|
|
|
CDS
|
[NCBI]
|
0.000547958
|
|
|
PPARA
|
[NCBI]
|
0.000543501
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
0.000514562
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000502896
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
0.000496835
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
0.000487921
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
0.000463059
|
|
|
NIDDM
|
[NCBI]
|
0.000419288
|
|
|
LIPC
|
[NCBI]
|
0.000403565
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
0.000383692
|
|
|
FPLD2
|
[NCBI]
|
0.000344418
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
0.000344418
|
|
|
PLTP
|
[NCBI]
|
0.000332804
|
|
|
TGD
|
[NCBI]
|
0.000323616
|
|
|
EGF
|
[NCBI]
|
0.000289779
|
|
|
VEGF
|
[NCBI]
|
0.000287808
|
|
|
CGL2
|
[NCBI]
|
0.000278141
|
|
|
triglyceride storage disease, type ii
|
[NCBI]
|
0.000254667
|
|
|
GIP
|
[NCBI]
|
0.000241775
|
|
|
NGFB
|
[NCBI]
|
0.000215783
|
|
|
RA
|
[NCBI]
|
0.000214781
|
|
|
MADA
|
[NCBI]
|
0.000212113
|
|
|
MADB
|
[NCBI]
|
0.000211237
|
|
|
lipase deficiency, combined
|
[NCBI]
|
0.000191655
|
|
|
APOA5
|
[NCBI]
|
0.000185816
|
|
|
FED
|
[NCBI]
|
0.000174971
|
|
|
SCD
|
[NCBI]
|
0.000170645
|
|
|
CGL1
|
[NCBI]
|
0.000167978
|
|
|
hyperglycerolemia
|
[NCBI]
|
0.000167002
|
|
|
CMRD
|
[NCBI]
|
0.000152661
|
|
|
PRL
|
[NCBI]
|
0.000139243
|
|
|
wolman disease
|
[NCBI]
|
0.000136818
|
|
|
carnitine palmitoyltransferase i deficiency
|
[NCBI]
|
0.000136581
|
|
|
AVP
|
[NCBI]
|
0.000135816
|
|
|
LDLR
|
[NCBI]
|
0.000134607
|
|
|
APOC3
|
[NCBI]
|
0.000130763
|
|
|
SHBG
|
[NCBI]
|
0.000129377
|
|
|
ACHE
|
[NCBI]
|
0.000128647
|
|
|
triglyceride storage disease, type i
|
[NCBI]
|
0.000127286
|
|
|
acne, adult
|
[NCBI]
|
0.000127286
|
|
|
bile acid, synthetic defect of
|
[NCBI]
|
0.000127286
|
|
|
wolman disease with hypolipoproteinemia and acanthocytosis
|
[NCBI]
|
0.000127286
|
|
|
hyperlipoproteinemia, type iv
|
[NCBI]
|
0.000127286
|
|
|
APOA1
|
[NCBI]
|
0.000117626
|
|
|
KLK3
|
[NCBI]
|
0.000117516
|
|
|
TH
|
[NCBI]
|
0.000114024
|
|
|
GFAP
|
[NCBI]
|
0.000111746
|
|
|
LPG
|
[NCBI]
|
0.00011042
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
0.000105784
|
|
|
MTP
|
[NCBI]
|
0.000100696
|
|
|
PNPLA2
|
[NCBI]
|
0.000100696
|
|
|
refsum disease
|
[NCBI]
|
9.96648e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
9.78091e-05
|
|
|
PWS
|
[NCBI]
|
9.76892e-05
|
|
|
EPO
|
[NCBI]
|
9.67188e-05
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
9.60327e-05
|
|
|
acrogeria, gottron type
|
[NCBI]
|
9.57801e-05
|
|
|
hyperlipoproteinemia, type v
|
[NCBI]
|
9.57801e-05
|
|
|
hyperostosis frontalis interna
|
[NCBI]
|
9.57801e-05
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
9.43294e-05
|
|
|
VIP
|
[NCBI]
|
9.35934e-05
|
|
|
MPO
|
[NCBI]
|
9.23511e-05
|
|
|
ADRP
|
[NCBI]
|
8.88785e-05
|
|
|
CRH
|
[NCBI]
|
8.78844e-05
|
|
|
cholesteryl ester transfer protein deficiency
|
[NCBI]
|
8.39417e-05
|
|
|
AD
|
[NCBI]
|
8.23473e-05
|
|
|
MADD
|
[NCBI]
|
8.1543e-05
|
|
|
FABP2
|
[NCBI]
|
8.108e-05
|
|
|
CES1
|
[NCBI]
|
7.87642e-05
|
|
|
HGF
|
[NCBI]
|
7.80564e-05
|
|
|
ear wax, wet/dry
|
[NCBI]
|
7.62838e-05
|
|
|
ANGPTL3
|
[NCBI]
|
7.33266e-05
|
|
|
PTH
|
[NCBI]
|
7.28673e-05
|
|
|
AR
|
[NCBI]
|
6.89577e-05
|
|
|
FPLD3
|
[NCBI]
|
6.61083e-05
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
6.61083e-05
|
|
|
anderson disease
|
[NCBI]
|
6.61083e-05
|
|
|
CDSP
|
[NCBI]
|
6.5744e-05
|
|
|
INS
|
[NCBI]
|
6.53773e-05
|
|
|
PPARG
|
[NCBI]
|
5.96882e-05
|
|
|
mitochondrial myopathy with diabetes
|
[NCBI]
|
5.91968e-05
|
|
|
NPPA
|
[NCBI]
|
5.80514e-05
|
|
|
sea-blue histiocyte disease
|
[NCBI]
|
5.64263e-05
|
|
|
CEL
|
[NCBI]
|
5.49381e-05
|
|
|
ALMS
|
[NCBI]
|
5.17774e-05
|
|
|
VED
|
[NCBI]
|
4.97884e-05
|
|
|
ARH
|
[NCBI]
|
4.97884e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
4.97884e-05
|
|
|
CRC
|
[NCBI]
|
4.70142e-05
|
|
|
DGAT1
|
[NCBI]
|
4.38841e-05
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
4.3325e-05
|
|
|
CETP
|
[NCBI]
|
4.27375e-05
|
|
|
NR1H4
|
[NCBI]
|
4.08061e-05
|
|
|
SLC27A1
|
[NCBI]
|
3.99379e-05
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
3.95484e-05
|
|
|
APOC2
|
[NCBI]
|
3.90532e-05
|
|
|
OCRL
|
[NCBI]
|
3.73796e-05
|
|
|
PEMT
|
[NCBI]
|
3.55075e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
3.50524e-05
|
|
|
HIDS
|
[NCBI]
|
3.45232e-05
|
|
|
PPARD
|
[NCBI]
|
3.42392e-05
|
|
|
PFIC1
|
[NCBI]
|
3.28327e-05
|
|
|
FABP4
|
[NCBI]
|
3.088e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
2.85299e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
2.85299e-05
|
|
|
PON1
|
[NCBI]
|
2.81636e-05
|
|
|
LEP
|
[NCBI]
|
2.78321e-05
|
|
|
IDDM
|
[NCBI]
|
2.73234e-05
|
|
|
srebp cleavage-activating protein
|
[NCBI]
|
2.66226e-05
|
|
|
DGAT2
|
[NCBI]
|
2.65573e-05
|
|
|
apolipoprotein b48 receptor
|
[NCBI]
|
2.65573e-05
|
|
|
glycerol-3-phosphate acyltransferase 3
|
[NCBI]
|
2.65573e-05
|
|
|
CHRM3
|
[NCBI]
|
2.65573e-05
|
|
|
SLE
|
[NCBI]
|
2.62416e-05
|
|
|
VDR
|
[NCBI]
|
2.6158e-05
|
|
|
APOH
|
[NCBI]
|
2.56276e-05
|
|
|
glycogen storage disease vii
|
[NCBI]
|
2.50695e-05
|
|
|
CD36
|
[NCBI]
|
2.47915e-05
|
|
|
NPY
|
[NCBI]
|
2.4482e-05
|
|
|
CYP7A1
|
[NCBI]
|
2.36449e-05
|
|
|
LI1
|
[NCBI]
|
2.35722e-05
|
|
|
NR1H3
|
[NCBI]
|
2.28235e-05
|
|
|
ADA
|
[NCBI]
|
2.27567e-05
|
|
|
PTK2
|
[NCBI]
|
2.13355e-05
|
|
|
UCP1
|
[NCBI]
|
2.13189e-05
|
|
|
VLDLR
|
[NCBI]
|
2.09778e-05
|
|
|
ARMD1
|
[NCBI]
|
2.0937e-05
|
|
|
SHH
|
[NCBI]
|
2.0393e-05
|
|
|
ANGPTL4
|
[NCBI]
|
2.00968e-05
|
|
|
APOA4
|
[NCBI]
|
2.00968e-05
|
|
|
TF
|
[NCBI]
|
1.98464e-05
|
|
|
PLA2G7
|
[NCBI]
|
1.95216e-05
|
|
|
ELOVL2
|
[NCBI]
|
1.91715e-05
|
|
|
MOGAT1
|
[NCBI]
|
1.91715e-05
|
|
|
CIDEA
|
[NCBI]
|
1.91715e-05
|
|
|
g-substrate
|
[NCBI]
|
1.91715e-05
|
|
|
TXNIP
|
[NCBI]
|
1.89797e-05
|
|
|
SLC2A4
|
[NCBI]
|
1.88528e-05
|
|
|
SMS
|
[NCBI]
|
1.73534e-05
|
|
|
ACADM
|
[NCBI]
|
1.67174e-05
|
|
|
RRAD
|
[NCBI]
|
1.64072e-05
|
|
|
CHK
|
[NCBI]
|
1.64072e-05
|
|
|
AADAC
|
[NCBI]
|
1.64072e-05
|
|
|
CJD
|
[NCBI]
|
1.60072e-05
|
|
|
UCP2
|
[NCBI]
|
1.6001e-05
|
|
|
COMT
|
[NCBI]
|
1.56073e-05
|
|
|
PPARGC1A
|
[NCBI]
|
1.55152e-05
|
|
|
LRP1
|
[NCBI]
|
1.49003e-05
|
|
|
EIF2AK4
|
[NCBI]
|
1.46253e-05
|
|
|
FGF21
|
[NCBI]
|
1.46253e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.42407e-05
|
|
|
SLC2A10
|
[NCBI]
|
1.331e-05
|
|
|
PLA1A
|
[NCBI]
|
1.331e-05
|
|
|
GPAM
|
[NCBI]
|
1.331e-05
|
|
|
GPR109B
|
[NCBI]
|
1.331e-05
|
|
|
CDKAL1
|
[NCBI]
|
1.331e-05
|
|
|
PDE3B
|
[NCBI]
|
1.331e-05
|
|
|
ALB
|
[NCBI]
|
1.32527e-05
|
|
|
IGF1R
|
[NCBI]
|
1.30364e-05
|
|
|
SEPS1
|
[NCBI]
|
1.22694e-05
|
|
|
LMF1
|
[NCBI]
|
1.22694e-05
|
|
|
PRKAR2B
|
[NCBI]
|
1.22694e-05
|
|
|
VGF
|
[NCBI]
|
1.22694e-05
|
|
|
AGPAT2
|
[NCBI]
|
1.22694e-05
|
|
|
SOAT2
|
[NCBI]
|
1.22694e-05
|
|
|
CFHR4
|
[NCBI]
|
1.22694e-05
|
|
|
F3
|
[NCBI]
|
1.16692e-05
|
|
|
LEPR
|
[NCBI]
|
1.14346e-05
|
|
|
PCK1
|
[NCBI]
|
1.14105e-05
|
|
|
IGF2BP2
|
[NCBI]
|
1.14105e-05
|
|
|
ARMET
|
[NCBI]
|
1.14105e-05
|
|
|
LIPE
|
[NCBI]
|
1.14105e-05
|
|
|
SLC30A8
|
[NCBI]
|
1.14105e-05
|
|
|
NDST1
|
[NCBI]
|
1.14105e-05
|
|
|
MMP3
|
[NCBI]
|
1.09241e-05
|
|
|
LMNA
|
[NCBI]
|
1.08114e-05
|
|
|
LRPAP1
|
[NCBI]
|
1.06806e-05
|
|
|
SLC27A4
|
[NCBI]
|
1.06806e-05
|
|
|
LPA
|
[NCBI]
|
1.05233e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
1.03161e-05
|
|
|
POMC
|
[NCBI]
|
1.02138e-05
|
|
|
GCKR
|
[NCBI]
|
1.00471e-05
|
|
|
FACL2
|
[NCBI]
|
1.00471e-05
|
|
|
glycogen storage disease vi
|
[NCBI]
|
1.00471e-05
|
|
|
RP1
|
[NCBI]
|
1.00471e-05
|
|
|
TNF
|
[NCBI]
|
9.91846e-06
|
|
|
ABCA1
|
[NCBI]
|
9.60651e-06
|
|
|
EPHX2
|
[NCBI]
|
9.48861e-06
|
|
|
ACACB
|
[NCBI]
|
9.48861e-06
|
|
|
MLYCD
|
[NCBI]
|
9.48861e-06
|
|
|
lipase, congenital absence of pancreatic
|
[NCBI]
|
9.48861e-06
|
|
|
RORA
|
[NCBI]
|
9.48861e-06
|
|
|
WBS
|
[NCBI]
|
9.36199e-06
|
|
|
CNTF
|
[NCBI]
|
9.12946e-06
|
|
|
INSIG1
|
[NCBI]
|
8.98992e-06
|
|
|
INSIG2
|
[NCBI]
|
8.98992e-06
|
|
|
GYS1
|
[NCBI]
|
8.98992e-06
|
|
|
TTR
|
[NCBI]
|
8.9556e-06
|
|
|
ESR1
|
[NCBI]
|
8.86662e-06
|
|
|
CF
|
[NCBI]
|
8.78543e-06
|
|
|
CDKN2B
|
[NCBI]
|
8.54014e-06
|
|
|
ZS
|
[NCBI]
|
8.42821e-06
|
|
|
SPP1
|
[NCBI]
|
8.15058e-06
|
|
|
HHEX
|
[NCBI]
|
8.13107e-06
|
|
|
AEBP1
|
[NCBI]
|
8.13107e-06
|
|
|
APOBEC1
|
[NCBI]
|
8.13107e-06
|
|
|
NR1D1
|
[NCBI]
|
8.13107e-06
|
|
|
APC
|
[NCBI]
|
8.12473e-06
|
|
|
PF4
|
[NCBI]
|
7.92167e-06
|
|
|
MB
|
[NCBI]
|
7.85636e-06
|
|
|
TFPI
|
[NCBI]
|
7.82873e-06
|
|
|
LDLRAP1
|
[NCBI]
|
7.75645e-06
|
|
|
AQP9
|
[NCBI]
|
7.75645e-06
|
|
|
AQP7
|
[NCBI]
|
7.41133e-06
|
|
|
CPT1A
|
[NCBI]
|
7.41133e-06
|
|
|
GNPAT
|
[NCBI]
|
7.41133e-06
|
|
|
FGF7
|
[NCBI]
|
7.27573e-06
|
|
|
FRAP1
|
[NCBI]
|
7.23879e-06
|
|
|
THBD
|
[NCBI]
|
7.09177e-06
|
|
|
PLIN
|
[NCBI]
|
6.79457e-06
|
|
|
PIK3R1
|
[NCBI]
|
6.79457e-06
|
|
|
G6PD
|
[NCBI]
|
6.52753e-06
|
|
|
SCARB1
|
[NCBI]
|
6.51709e-06
|
|
|
NR0B2
|
[NCBI]
|
6.27607e-06
|
|
|
SREBF1
|
[NCBI]
|
6.25714e-06
|
|
|
VCAM1
|
[NCBI]
|
6.01287e-06
|
|
|
ADRB3
|
[NCBI]
|
6.01287e-06
|
|
|
CCL2
|
[NCBI]
|
5.87746e-06
|
|
|
CAPN10
|
[NCBI]
|
5.78272e-06
|
|
|
P4HB
|
[NCBI]
|
5.78272e-06
|
|
|
CCR2
|
[NCBI]
|
5.78272e-06
|
|
|
RETN
|
[NCBI]
|
5.78272e-06
|
|
|
DLL4
|
[NCBI]
|
5.78272e-06
|
|
|
ACACA
|
[NCBI]
|
5.35954e-06
|
|
|
GPT
|
[NCBI]
|
5.07484e-06
|
|
|
UCP3
|
[NCBI]
|
4.91221e-06
|
|
|
MTND2
|
[NCBI]
|
4.634e-06
|
|
|
ACPP
|
[NCBI]
|
4.59679e-06
|
|
|
CREB1
|
[NCBI]
|
4.47332e-06
|
|
|
PTPN1
|
[NCBI]
|
4.47332e-06
|
|
|
CLU
|
[NCBI]
|
4.45449e-06
|
|
|
CD
|
[NCBI]
|
4.18127e-06
|
|
|
TLR4
|
[NCBI]
|
4.11616e-06
|
|
|
CAV1
|
[NCBI]
|
4.03192e-06
|
|
|
DMD
|
[NCBI]
|
3.7845e-06
|
|
|
PTHLH
|
[NCBI]
|
3.77381e-06
|
|
|
IRS2
|
[NCBI]
|
3.76719e-06
|
|
|
KCNJ11
|
[NCBI]
|
3.76719e-06
|
|
|
STAT3
|
[NCBI]
|
3.67443e-06
|
|
|
GH1
|
[NCBI]
|
3.6576e-06
|
|
|
CPB2
|
[NCBI]
|
3.53825e-06
|
|
|
FASN
|
[NCBI]
|
3.52278e-06
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
3.18936e-06
|
|
|
PAI1
|
[NCBI]
|
3.18936e-06
|
|
|
FOXO1A
|
[NCBI]
|
3.18936e-06
|
|
|
ADRB2
|
[NCBI]
|
2.98651e-06
|
|
|
GK
|
[NCBI]
|
2.89032e-06
|
|
|
HP
|
[NCBI]
|
2.80402e-06
|
|
|
SIRT1
|
[NCBI]
|
2.7076e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
2.69919e-06
|
|
|
USF1
|
[NCBI]
|
2.45545e-06
|
|
|
TCF7L2
|
[NCBI]
|
2.30049e-06
|
|
|
AGT
|
[NCBI]
|
2.01834e-06
|
|
|
FXN
|
[NCBI]
|
1.95306e-06
|
|
|
SERPINA6
|
[NCBI]
|
1.94608e-06
|
|
|
SLOS
|
[NCBI]
|
1.80437e-06
|
|
|
RP
|
[NCBI]
|
1.76587e-06
|
|
|
APRT
|
[NCBI]
|
1.71217e-06
|
|
|
GHR
|
[NCBI]
|
1.67408e-06
|
|
|
IGF2
|
[NCBI]
|
1.44512e-06
|
|
|
ATF3
|
[NCBI]
|
1.44512e-06
|
|
|
APCS
|
[NCBI]
|
1.39645e-06
|
|
|
DBI
|
[NCBI]
|
1.14723e-06
|
|
|
CYP19A1
|
[NCBI]
|
1.13182e-06
|
|
|
NOTCH1
|
[NCBI]
|
1.13182e-06
|
|
|
MC4R
|
[NCBI]
|
9.08435e-07
|
|
|
ADCYAP1
|
[NCBI]
|
8.86045e-07
|
|
|
IL6
|
[NCBI]
|
8.57037e-07
|
|
|
ABP1
|
[NCBI]
|
8.4849e-07
|
|
|
SST
|
[NCBI]
|
8.18311e-07
|
|
|
FAAH
|
[NCBI]
|
7.15777e-07
|
|
|
MODY
|
[NCBI]
|
6.65413e-07
|
|
|
GRP
|
[NCBI]
|
6.59426e-07
|
|
|
CAT
|
[NCBI]
|
5.40979e-07
|
|
|
MDD
|
[NCBI]
|
4.34928e-07
|
|
|
LCT
|
[NCBI]
|
3.70563e-07
|
|
|
PYY
|
[NCBI]
|
3.22024e-07
|
|
|
GAL
|
[NCBI]
|
2.80162e-07
|
|
|
GNAS
|
[NCBI]
|
2.27702e-07
|
|
|
BCHE
|
[NCBI]
|
2.0494e-07
|
|
|
PTGS2
|
[NCBI]
|
1.89277e-07
|
|
|
ABCB11
|
[NCBI]
|
1.77407e-07
|
|
|
ACE
|
[NCBI]
|
1.66783e-07
|
|
|
PMCH
|
[NCBI]
|
1.6675e-07
|
|
|
ATM
|
[NCBI]
|
1.34397e-07
|
|
|
LBP
|
[NCBI]
|
1.34397e-07
|
|
|
AGER
|
[NCBI]
|
1.29405e-07
|
|
|
CDKN2A
|
[NCBI]
|
1.24722e-07
|
|
|
PSEN1
|
[NCBI]
|
8.93463e-08
|
|
|
ALD
|
[NCBI]
|
4.49852e-08
|
|
|
SDC2
|
[NCBI]
|
1.86031e-08
|
|
|
STAT5A
|
[NCBI]
|
1.67628e-08
|
|
|
CCK
|
[NCBI]
|
1.59348e-08
|
|
|
CP
|
[NCBI]
|
5.88425e-09
|
|
|
IFNA1
|
[NCBI]
|
3.95957e-09
|
|